Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Groupe Doliam is a French private industrial holding company and accelerator specializing in deep tech and medical technologies (MedTech). Founded in 1991, the group manages a prestigious portfolio of subsidiaries, including Vermon, a global leader in ultrasound transducer technology, and Cairdac, which developed the first self-sustainable leadless pacemaker. Doliam supports its companies through the entire lifecycle, from early-stage R&D to large-scale industrialization, with a strong focus on micro-electronics, MEMS, and energy harvesting for medical implants. The group is currently spearheading the MedTech Industrial Campus in Grenoble, a massive facility designed to accelerate the go-to-market process for innovative medical devices and micro-technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Groupe Doliam.